Last reviewed · How we verify

NCT04099173: MB-SI

A Brief Mindfulness-Based Intervention for Suicidal Ideation

Completed NA Last updated 11 May 2023
What this trial tests

NA trial testing Brief Mindfulness Based Intervention in Suicidal Ideation in 25 participants. Completed in 5 January 2023.

Timeline
1 September 2019
Primary endpoint
5 January 2023
5 January 2023

Quick facts

Lead sponsorVA Salt Lake City Health Care System
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment25
Start date1 September 2019
Primary completion5 January 2023
Estimated completion5 January 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

VA Salt Lake City Health Care System

Who can join

Adults 18 to 70, any sex, with Suicidal Ideation or Psychiatric Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim of this study is to determine whether a Brief Mindfulness-Based Intervention for Suicidal Ideation (MB-SI) is feasible and safe to implement. The secondary aims are short and longer-term reduction in suicidal ideation (SI) and/or suicide-related behaviors (SRBs) as well as improvements in mindfulness and emotional regulation measures compared to Treatment as Usual (TAU).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Randomized Controlled Trial of a Brief Mindfulness-Based Intervention for Suicidal Ideation Among Veterans.
    Herrmann TS, Nazarenko E, Marchand W, Day A, et al · · 2024 · cited 2× · PMID 36208303 · DOI 10.1093/milmed/usac291

Verify or expand the search:

Other recruiting trials for Suicidal Ideation

Currently open trials in the same condition.

Other VA Salt Lake City Health Care System trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04099173.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing